Tumoral indoleamine 2,3-dioxygenase expression predicts poor outcome in laryngeal squamous cell carcinoma (Q39514618)

12 September 2017

title

Tumoral indoleamine 2,3-dioxygenase expression predicts poor outcome in laryngeal squamous cell carcinoma (English)

1 reference

12 September 2017

0 references

Jin Ye

1

1 reference

12 September 2017

Hui Liu

2

1 reference

12 September 2017

Yanming Hu

3

1 reference

12 September 2017

Peng Li

4

1 reference

12 September 2017

Gehua Zhang

5

1 reference

12 September 2017

Yuan Li

6

1 reference

12 September 2017

publication date

20 November 2012

1 reference

12 September 2017

1 reference

12 September 2017

volume

462

1 reference

12 September 2017

issue

1

1 reference

12 September 2017

page(s)

73-81

1 reference

Indoleamine 2,3-dioxygenase, immunosuppression and pregnancy

12 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS00428-012-1340-X

Indoleamine 2,3-dioxygenase expression in human cancers: clinical and immunologic perspectives

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-012-1340-X

Indoleamine 2,3-dioxygenase as a modifier of pathogenic inflammation in cancer and other inflammation-associated diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-012-1340-X

Evidence for a tumoral immune resistance mechanism based on tryptophan degradation by indoleamine 2,3-dioxygenase

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-012-1340-X

Inhibition of allogeneic T-cell responses by dendritic cells expressing transduced indoleamine 2,3-dioxygenase

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-012-1340-X

Spontaneous cytotoxic T-Cell reactivity against indoleamine 2,3-dioxygenase-2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-012-1340-X

Cells expressing indoleamine 2,3-dioxygenase inhibit T cell responses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-012-1340-X

Indoleamine 2,3-dioxygenase, an emerging target for anti-cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-012-1340-X

The clinical implications of antitumor immunity in head and neck cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-012-1340-X

Expression and prognosis role of indoleamine 2,3-dioxygenase in hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-012-1340-X

Expression of indoleamine 2,3-dioxygenase in tumor endothelial cells correlates with long-term survival of patients with renal cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-012-1340-X

Prognostic value of indoleamine 2,3-dioxygenase expression in colorectal cancer: effect on tumor-infiltrating T cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-012-1340-X

Indoleamine 2,3-dioxygenase serves as a marker of poor prognosis in gene expression profiles of serous ovarian cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-012-1340-X

Hypoxia-inducible factor-1 alpha contributes to hypoxia-induced chemoresistance in gastric cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-012-1340-X

Increased tryptophan degradation in patients with bronchus carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-012-1340-X

Increased serum kynurenine/tryptophan ratio correlates with disease progression in lung cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-012-1340-X

Upregulated expression of indoleamine 2, 3-dioxygenase in primary breast cancer correlates with increase of infiltrated regulatory T cells in situ and lymph node metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-012-1340-X

Expression and prognostic impact of indoleamine 2,3-dioxygenase in oral squamous cell carcinomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-012-1340-X

Localization of indoleamine 2,3-dioxygenase in human esophageal squamous cell carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-012-1340-X

Involvement of indoleamine 2,3-dioxygenase in impairing tumor-infiltrating CD8 T-cell functions in esophageal squamous cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-012-1340-X

T regulatory cells in cancer: recent advances and therapeutic potential

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-012-1340-X

Intratumoral T cells, recurrence, and survival in epithelial ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-012-1340-X

Inverse correlation between tumoral indoleamine 2,3-dioxygenase expression and tumor-infiltrating lymphocytes in endometrial cancer: its association with disease progression and survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-012-1340-X

Regulatory T cells and Foxp3

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-012-1340-X

Using an ancient tool for igniting and propagating immune tolerance: IDO as an inducer and amplifier of regulatory T cell functions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-012-1340-X

Upregulated expression of indoleamine 2, 3-dioxygenase in CHO cells induces apoptosis of competent T cells and increases proportion of Treg cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-012-1340-X

The indoleamine 2,3-dioxygenase pathway is essential for human plasmacytoid dendritic cell-induced adaptive T regulatory cell generation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-012-1340-X

Indoleamine 2,3-dioxygenase in T-cell tolerance and tumoral immune escape.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-012-1340-X

Current trends in initial management of laryngeal cancer: the declining use of open surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-012-1340-X

Multidisciplinary management of laryngeal carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-012-1340-X

Current opinion in diagnosis and treatment of laryngeal carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-012-1340-X

Predictive value of MMP-7 expression for response to chemotherapy and survival in patients with non-small cell lung cancer

21 January 2018

1 reference

12 December 2020

Histological grade, perineural infiltration, tumour-infiltrating lymphocytes and apoptosis as determinants of long-term prognosis in prostatic adenocarcinoma

1 reference

12 December 2020

Targeting the immunoregulatory indoleamine 2,3 dioxygenase pathway in immunotherapy

1 reference

12 December 2020

Indoleamine 2,3-dioxygenase, Tregs and cancer

1 reference

12 December 2020

Expression of indoleamine 2, 3-dioxygenase and the recruitment of Foxp3-expressing regulatory T cells in the development and progression of uterine cervical cancer

1 reference

12 December 2020

Prognostic value of tumour-infiltrating lymphocytes (TILs) in colorectal cancer

1 reference

12 December 2020

10.1007/S00428-012-1340-X

Identifiers

DOI

1 reference

12 September 2017

1 reference